Company Profile

Omicron Biochemicals, Inc. develops new and improved methods to introduce stable isotopes into biologically-important compounds. Omicron specializes in the synthesis of labeled carbohydrates, nucleosides, and their derivatives, but will undertake the synthesis of other classes of compounds on a custom basis. Omicron's particular strengths lie in the preparation of site-specifically labeled compounds, but we are also capable of producing uniformly labeled products. The approaches used in synthesis include chemical, chemi-enzymic, enzymic and biological methods. Company also collaborates with other laboratories as needed to develop new products or distribute our products.